Identity
- Security key
- 14964
- Ticker
- ETON
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2018-11-14
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- ETON
Detail
Enriched 2026-08-14 20:47
- Market cap
- $1,138,974,245.64
- Shares outstanding (class)
- 27,392,358
- Shares outstanding (weighted)
- 27,392,358
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 44
- Location
- DEER PARK, IL
- Homepage
- https://www.etonpharma.com
- Description
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
Market cap and share counts drift.